Log in
CBH Conference
Log in

Jobs

6 days ago

Postdoctoral

Dalhousie University -

A funded Postdoctoral Fellow opportunity is available in Dr. Finlay Maguire’s group in the Computer Science / Community Health & Epidemiology at Dalhousie University.

This is a full-time one-year position, with the possibility of extension, at the University of Dalhousie. This position is supported by a New Frontiers in Research Fund Explore grant with Dr. Samira Mubareka at Sunnybrook Research Institute/University of Toronto, Dr. Arinjay Banerjee at the Vaccine and Infectious Disease Organisation/University of Saskatchewan, and Dr. Jeff Bowman at Ontario Ministry of Natural Resources/University of Trent.

78 days ago

Postdoctoral

Sunnybrook Research Institute & University of Toronto -

A 2-year (renewable) full-time postdoctoral fellowship is available in the laboratory of Prof. Alain Dabdoub. The position focuses on decoding the molecular landscape of the human inner ear during development and regeneration and translating these findings to advance therapeutic strategies. Our research investigates mechanisms that regulate auditory and vestibular homeostasis, the regeneration of sensory hair cells, stria vascularis, and auditory neurons as well as the implications for therapies and understanding disorders associated with aging, hearing loss, and balance dysfunction. Our projects combine state of-the-art computational tools and cutting-edge biological experiments.

132 days ago

Postdoctoral

University of Calgary - Cumming School of Medicine -

The Morrissy Lab is seeking a highly motivated scientist with expertise in bioinformatics and data science to join our team as a Postdoctoral Associate focused on understanding immunotherapy responses in solid tumors. The candidate will use state-of-the-art analytic approaches to investigate multi-omics data and derive an in-depth understanding of tumor ecosystem dynamics in clinical samples from immunotherapy trials – including phenotypic and functional cell heterogeneity, tumor and microenvironment cell niches, and cellular crosstalk. This research is primarily focused on cohorts of single-patient and phase I clinical trial participants treated with CAR T-cells (see Zemp el, 2024, in revision at Nature; preprint on medRxiv), and identifying mechanisms of immunotherapy response and resistance from longitudinally-collected blood and tumor tissue samples. The candidate will employ innovative bioinformatics and machine learning approaches to integrate single cell and spatial datasets from clinical samples with data from ongoing preclinical studies, further incorporating genomics and proteomics profiles from in-house or public repositories.

138 days ago

Postdoctoral

Epitopea Inc -

About Epitopea

Epitopea is a biotech company developing next-generation cancer immunotherapies. Using our Cryptigen™ platform, we combine immunopeptidomics and transcriptomics to identify shared tumor-specific antigens. By integrating multi-omic datasets with advanced computational methods, we aim to create accessible, off-the-shelf cancer vaccines for patients.

The Opportunity

We are seeking a Postdoctoral Fellow in Computational Biology to join Epitopea’s ASCEND Fellowship program. This is a unique opportunity to contribute to translational research at the interface of immunology, cancer biology, and computational science, while receiving tailored career development support from adMare BioInnovations.

The Fellow will work closely with Epitopea’s multidisciplinary team of wet-lab scientists and computational biologists. This is a rare opportunity to join a growing biotech company at a formative stage and to make a direct impact on early vaccine development.

This role is based in Montreal, QC, Canada and requires on-site presence.

French version:

À propos d’Epitopea

Epitopea est une entreprise de biotechnologie qui développe des immunothérapies de nouvelle génération contre le cancer. À l’aide de notre plateforme Cryptigen™, nous combinons l’immunopeptidomique et la transcriptomique pour identifier des antigènes communs spécifiques aux tumeurs. En intégrant des ensembles de données multi-omiques à des méthodes computationnelles avancées, nous visons à créer des vaccins contre le cancer accessibles et “off-the-shelf”, pouvant bénéficier à un grand nombre de patients.

L’opportunité

Nous recherchons un chercheur postdoctoral en biologie computationnelle pour rejoindre le programme de bourses ASCEND d’Epitopea. Il s’agit d’une occasion unique de contribuer à la recherche translationnelle à l’interface de l’immunologie, de la biologie du cancer et des sciences computationnelles, tout en bénéficiant d’un soutien personnalisé en matière de développement de carrière de la part d’adMare BioInnovations.

Le boursier travaillera en étroite collaboration avec l’équipe multidisciplinaire d’Epitopea, composée de scientifiques de laboratoire et de biologistes computationnels. Il s’agit d’une occasion rare de rejoindre une entreprise de biotechnologie en pleine croissance à un stade formatif et d’avoir un impact direct sur le développement de nos vaccins.

Ce poste est basé à Montréal (Québec, Canada) et nécessite une présence sur site.

237 days ago

Postdoctoral

The COBRA Lab (thecobralab.com), University of Alberta -

RNA therapeutics are reshaping modern medicine—from mRNA vaccines to precision gene modulation. At the COBRA Lab, we advance computational methods that connect RNA structure to function and translate those insights into tangible health benefits. Joining our team means collaborating with researchers across disciplines, seeing your algorithms inform real-world therapies, and contributing to an inclusive scientific community committed to open, rigorous inquiry.

Appointment

  • Term: One year with possibility of renewal
  • Salary: CAD $70,000 per year, plus full University of Alberta benefits
  • Start date: Flexible (applications reviewed on a rolling basis)
  • Work mode: On site in Edmonton

Research Focus

You will collaborate on projects that:

  • Characterise RNA structure–function relationships
  • Improve RNA efficiency through informed RNA design
  • Predict the effects of genetic mutations on RNA behaviour

All projects share the goal of accelerating RNA-based therapeutic development.